DK1183228T3 - Estere af L-carnitin eller alkanoyl-L-carnitiner - Google Patents
Estere af L-carnitin eller alkanoyl-L-carnitinerInfo
- Publication number
- DK1183228T3 DK1183228T3 DK00922852T DK00922852T DK1183228T3 DK 1183228 T3 DK1183228 T3 DK 1183228T3 DK 00922852 T DK00922852 T DK 00922852T DK 00922852 T DK00922852 T DK 00922852T DK 1183228 T3 DK1183228 T3 DK 1183228T3
- Authority
- DK
- Denmark
- Prior art keywords
- carnitines
- carnitine
- alkanoyl
- esters
- chem
- Prior art date
Links
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 title abstract 2
- 150000002148 esters Chemical class 0.000 title abstract 2
- -1 alkanoyl L-carnitines Chemical class 0.000 abstract 1
- 125000002091 cationic group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000003834 intracellular effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Birds (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Emergency Medicine (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT1999RM000220A IT1306129B1 (it) | 1999-04-13 | 1999-04-13 | Esteri della l-carnitina o di alcanoil l-carnitine utilizzabili comelipidi cationici per l'immissione intracellulare di composti |
| PCT/IT2000/000137 WO2000061543A2 (fr) | 1999-04-13 | 2000-04-11 | Esters de l-carnitine ou de l-carnitines alcanoyles utilises comme lipides cationiques pour un apport intracellulaire de composes actifs d'un point de vue pharmacologique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1183228T3 true DK1183228T3 (da) | 2005-05-17 |
Family
ID=11406659
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03020049T DK1426044T3 (da) | 1999-04-13 | 2000-04-11 | Anvendelse af estere af L-carnitin eller alkanoyl-L-carnitiner som kationiske lipider til intracellulær tilförsel af farmakologisk aktive forbindelser |
| DK00922852T DK1183228T3 (da) | 1999-04-13 | 2000-04-11 | Estere af L-carnitin eller alkanoyl-L-carnitiner |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03020049T DK1426044T3 (da) | 1999-04-13 | 2000-04-11 | Anvendelse af estere af L-carnitin eller alkanoyl-L-carnitiner som kationiske lipider til intracellulær tilförsel af farmakologisk aktive forbindelser |
Country Status (34)
| Country | Link |
|---|---|
| US (4) | US6797281B1 (fr) |
| EP (3) | EP1435232A1 (fr) |
| JP (2) | JP4703855B2 (fr) |
| KR (2) | KR100684378B1 (fr) |
| CN (2) | CN100402017C (fr) |
| AT (2) | ATE286873T1 (fr) |
| AU (2) | AU776301B2 (fr) |
| BG (3) | BG65501B1 (fr) |
| BR (2) | BRPI0017460B1 (fr) |
| CA (2) | CA2370143C (fr) |
| CZ (1) | CZ302628B6 (fr) |
| DE (2) | DE60017388T2 (fr) |
| DK (2) | DK1426044T3 (fr) |
| EA (2) | EA004459B1 (fr) |
| EE (2) | EE05719B1 (fr) |
| ES (2) | ES2234591T3 (fr) |
| HK (2) | HK1045145B (fr) |
| HR (1) | HRP20010740B1 (fr) |
| HU (1) | HU229366B1 (fr) |
| IL (4) | IL145765A0 (fr) |
| IS (2) | IS2476B (fr) |
| IT (1) | IT1306129B1 (fr) |
| ME (2) | MEP24008A (fr) |
| MX (1) | MXPA01010359A (fr) |
| NO (2) | NO327742B1 (fr) |
| NZ (2) | NZ528874A (fr) |
| PL (2) | PL204418B1 (fr) |
| PT (2) | PT1426044E (fr) |
| RS (3) | RS20090448A (fr) |
| SI (2) | SI1183228T1 (fr) |
| SK (2) | SK287253B6 (fr) |
| TR (2) | TR200202358T2 (fr) |
| WO (1) | WO2000061543A2 (fr) |
| ZA (1) | ZA200109291B (fr) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7151191B2 (en) * | 2000-01-13 | 2006-12-19 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
| DE10113446A1 (de) † | 2001-03-19 | 2002-09-26 | Schwarzkopf Gmbh Hans | Haarbehandlungsmittel mit Betainen |
| PT2286795T (pt) * | 2002-06-26 | 2017-01-27 | Syncore Biotechnology Co Ltd | Processo de produção de uma preparação lipossomal catiónica que compreende um composto lipófilo |
| ATE444062T1 (de) * | 2002-06-26 | 2009-10-15 | Medigene Ag | Herstellung einer kationisch liposomalen zubereitung, einen lipophilen wirkstoff enthaltend |
| ITRM20040288A1 (it) * | 2004-06-11 | 2004-09-11 | Sigma Tau Ind Farmaceuti | Uso della 7-t-butossiimminometilcamptotecina per la preparazione di un medicamento per il trattamento delle neoplasie dell'utero. |
| GT200500310A (es) * | 2004-11-19 | 2006-06-19 | Compuestos organicos | |
| EP1868571A4 (fr) * | 2005-03-02 | 2011-10-26 | Univ Northeastern | Vesicules phospholipidiques mitochondriotropes |
| SA06270147B1 (ar) | 2005-06-09 | 2009-12-22 | نوفارتيس ايه جي | عملية لتخليق 5-(مثيل–1h–إيميدازول–1-يل )–3-(ثلاثي فلـورو مثيل)–بنزامـين |
| CA2617873A1 (fr) * | 2005-08-10 | 2007-02-15 | Novartis Ag | Formulations pour 7-(t-butoxy)iminomethyl camptothecine |
| TW200800195A (en) * | 2005-08-10 | 2008-01-01 | Novartis Ag | Organic compounds |
| WO2008024389A2 (fr) * | 2006-08-23 | 2008-02-28 | Biodelivery Sciences International, Inc. | Compositions nucléotide-cochléate amphiphiles et procédés d'utilisation de celles-ci |
| US20100166843A1 (en) * | 2007-02-01 | 2010-07-01 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Pharmaceutical composition comprising a campothecin derivative |
| US20100104625A1 (en) * | 2007-02-16 | 2010-04-29 | Cornell University | Biodegradable compositions and materials |
| US20100204432A1 (en) | 2007-05-28 | 2010-08-12 | Husam Younes | Biodegradable elastomers prepared by the condensation of an organic di-, tri- or tetra-carboxylic acid and an organic diol |
| US7858666B2 (en) | 2007-06-08 | 2010-12-28 | Mannkind Corporation | IRE-1α inhibitors |
| WO2009114763A2 (fr) | 2008-03-13 | 2009-09-17 | Perkinelmer Las, Inc. | Substrats enzymatiques pour systèmes de détection multiples |
| EP2532649B1 (fr) * | 2011-06-07 | 2015-04-08 | Incella GmbH | Lipides aminés, leur synthèse et utilisations associées |
| WO2013032643A2 (fr) * | 2011-08-31 | 2013-03-07 | Dicerna Pharmaceuticals, Inc. | Lipides pouvant supporter un changement conformationnel et utilisation de ces derniers dans des formulations afin d'apporter des agents thérapeutiques à des cellules |
| US20140274798A1 (en) | 2013-03-15 | 2014-09-18 | University Of Washington Through Its Center For Commercialization | Compounds and methods relating to lysosomal storage disorders |
| CN109069440A (zh) | 2016-03-02 | 2018-12-21 | 得克萨斯州大学系统董事会 | 用于免疫治疗的激活sting的纳米疫苗 |
| WO2018226854A2 (fr) * | 2017-06-06 | 2018-12-13 | Wayne State University | Revêtements polymères antisalissure et procédé de revêtement inverse |
| CN115177608B (zh) * | 2022-07-26 | 2023-12-05 | 南方医科大学南方医院 | 长链酰基肉碱类化合物在制备预防和/或治疗肝癌的药物中的应用 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4866040A (en) * | 1986-01-06 | 1989-09-12 | Alfred Stracher | Aminocarnitine directed pharmaceutical agents |
| US5008288A (en) * | 1986-01-06 | 1991-04-16 | Alfred Stracher | Carnitine directed pharmaceutical agents |
| IT1230142B (it) * | 1989-05-03 | 1991-10-14 | Fidia Spa | Derivati della carnitina, processo per la loro preparazione e impiego in terapia umana |
| AU660417B2 (en) * | 1990-06-15 | 1995-06-29 | University Of North Carolina At Chapel Hill, The | Ether lipid-nucleoside covalent conjugates |
| IT1248321B (it) * | 1991-05-15 | 1995-01-05 | Sigma Tau Ind Farmaceuti | Uso di esteri di acil l-carnitine con l'acido gamma-idrossibutirrico per produrre composizioni farmaceutiche per il trattamento di epatopatie |
| IT1258370B (it) * | 1992-03-02 | 1996-02-26 | Sigma Tau Ind Farmaceuti | Esteri della l-carnitina e di acil l-carnitine dotati di attivita' miorilassante selettiva sull'apparato gastro-intestinale e composizioni farmaceutiche che li contengono. |
| US5972600A (en) * | 1992-04-03 | 1999-10-26 | The Regents Of The University Of California | Separation of active complexes |
| IT1263013B (it) * | 1992-10-20 | 1996-07-23 | Avantgarde Spa | Esteri della l-carnitina e di alcanoil l-carnitine con l'acido glicolico o suoi esteri e composizioni farmaceutiche contenenti tali per il trattamento di affezioni cutanee. |
| US5552156A (en) * | 1992-10-23 | 1996-09-03 | Ohio State University | Liposomal and micellular stabilization of camptothecin drugs |
| US5512671A (en) * | 1993-02-16 | 1996-04-30 | Wake Forest University | Ether lipid-nucleoside covalent conjugates |
| IT1261984B (it) * | 1993-06-22 | 1996-06-11 | Avantgarde Spa | Uso di esteri della l-carnitina o di acil l- carnitine con idrossiacidi per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee. |
| DE69407292T2 (de) * | 1993-06-30 | 1998-06-25 | Genentech Inc | Verfahren zur herstellung von liposomen |
| IT1273987B (it) * | 1994-09-29 | 1997-07-14 | Sigma Tau Ind Farmaceuti | Uso di esteri ftalidilidenici della carnitina e di alcanoil carnitine per il trattamento dello shock endotossico |
| US6008202A (en) * | 1995-01-23 | 1999-12-28 | University Of Pittsburgh | Stable lipid-comprising drug delivery complexes and methods for their production |
| US6316652B1 (en) * | 1995-06-06 | 2001-11-13 | Kosta Steliou | Drug mitochondrial targeting agents |
| US5811406A (en) * | 1995-06-07 | 1998-09-22 | Regents Of The University Of California | Dry powder formulations of polynucleotide complexes |
| WO1996040265A1 (fr) * | 1995-06-07 | 1996-12-19 | The Regents Of The University Of California | Stabilisation de complexes de polynucleotides |
| IT1283955B1 (it) * | 1996-03-20 | 1998-05-07 | Sigma Tau Ind Farmaceuti | Bis alcanoil esteri della carnitina ad attivita' antibatterica, antimicotica ed antiprotozoaria. |
| WO1998004720A1 (fr) * | 1996-07-26 | 1998-02-05 | Sloan-Kettering Institute For Cancer Research | Procedes et reactifs destines a l'immunisation genetique |
| US6056973A (en) * | 1996-10-11 | 2000-05-02 | Sequus Pharmaceuticals, Inc. | Therapeutic liposome composition and method of preparation |
| US6071532A (en) * | 1996-10-15 | 2000-06-06 | Emory University | Synthesis of glycophospholipid and peptide-phospholipid conjugates and uses thereof |
| IT1299172B1 (it) * | 1998-05-06 | 2000-02-29 | Sigma Tau Ind Farmaceuti | Esteri perfluorurati di alcanoil l-carnitine utilizzabili quali lipidi cationici per l'immissione intracellulare di composti |
-
1999
- 1999-04-13 IT IT1999RM000220A patent/IT1306129B1/it active
-
2000
- 2000-04-11 TR TR2002/02358T patent/TR200202358T2/xx unknown
- 2000-04-11 HU HU0201446A patent/HU229366B1/hu not_active IP Right Cessation
- 2000-04-11 SK SK1431-2001A patent/SK287253B6/sk not_active IP Right Cessation
- 2000-04-11 NZ NZ528874A patent/NZ528874A/en not_active IP Right Cessation
- 2000-04-11 CN CNB2005101295985A patent/CN100402017C/zh not_active Expired - Fee Related
- 2000-04-11 SK SK5094-2008A patent/SK288246B6/sk not_active IP Right Cessation
- 2000-04-11 ME MEP-240/08A patent/MEP24008A/xx unknown
- 2000-04-11 SI SI200030596T patent/SI1183228T1/xx unknown
- 2000-04-11 TR TR2001/02941T patent/TR200102941T2/xx unknown
- 2000-04-11 CZ CZ20013617A patent/CZ302628B6/cs not_active IP Right Cessation
- 2000-04-11 JP JP2000610820A patent/JP4703855B2/ja not_active Expired - Fee Related
- 2000-04-11 NZ NZ515270A patent/NZ515270A/xx not_active IP Right Cessation
- 2000-04-11 EA EA200101076A patent/EA004459B1/ru not_active IP Right Cessation
- 2000-04-11 RS RSP-2009/0448A patent/RS20090448A/sr unknown
- 2000-04-11 ME MEP-2008-240A patent/ME00113B/fr unknown
- 2000-04-11 DE DE60017388T patent/DE60017388T2/de not_active Expired - Lifetime
- 2000-04-11 CA CA2370143A patent/CA2370143C/fr not_active Expired - Fee Related
- 2000-04-11 DK DK03020049T patent/DK1426044T3/da active
- 2000-04-11 RS RS20090448A patent/RS52682B/en unknown
- 2000-04-11 DE DE60025961T patent/DE60025961T2/de not_active Expired - Lifetime
- 2000-04-11 EA EA200300745A patent/EA006021B1/ru not_active IP Right Cessation
- 2000-04-11 PT PT03020049T patent/PT1426044E/pt unknown
- 2000-04-11 PL PL351112A patent/PL204418B1/pl unknown
- 2000-04-11 EP EP04006990A patent/EP1435232A1/fr not_active Withdrawn
- 2000-04-11 EP EP03020049A patent/EP1426044B1/fr not_active Expired - Lifetime
- 2000-04-11 AU AU43123/00A patent/AU776301B2/en not_active Ceased
- 2000-04-11 BR BRPI0017460A patent/BRPI0017460B1/pt not_active IP Right Cessation
- 2000-04-11 EE EEP201100028A patent/EE05719B1/et not_active IP Right Cessation
- 2000-04-11 BG BG109876A patent/BG65501B1/bg unknown
- 2000-04-11 AT AT00922852T patent/ATE286873T1/de active
- 2000-04-11 WO PCT/IT2000/000137 patent/WO2000061543A2/fr active Application Filing
- 2000-04-11 DK DK00922852T patent/DK1183228T3/da active
- 2000-04-11 KR KR1020017013018A patent/KR100684378B1/ko not_active IP Right Cessation
- 2000-04-11 PL PL386640A patent/PL211710B1/pl unknown
- 2000-04-11 CA CA2650202A patent/CA2650202C/fr not_active Expired - Fee Related
- 2000-04-11 RS YUP-702/01A patent/RS50911B/sr unknown
- 2000-04-11 BR BRPI0009765-9B1A patent/BR0009765B1/pt not_active IP Right Cessation
- 2000-04-11 CN CNB008070539A patent/CN1263730C/zh not_active Expired - Fee Related
- 2000-04-11 EE EEP200100518A patent/EE05514B1/xx not_active IP Right Cessation
- 2000-04-11 SI SI200030799T patent/SI1426044T1/sl unknown
- 2000-04-11 EP EP00922852A patent/EP1183228B1/fr not_active Expired - Lifetime
- 2000-04-11 PT PT00922852T patent/PT1183228E/pt unknown
- 2000-04-11 ES ES00922852T patent/ES2234591T3/es not_active Expired - Lifetime
- 2000-04-11 AT AT03020049T patent/ATE317257T1/de active
- 2000-04-11 IL IL14576500A patent/IL145765A0/xx active IP Right Grant
- 2000-04-11 MX MXPA01010359A patent/MXPA01010359A/es active IP Right Grant
- 2000-04-11 KR KR1020067021555A patent/KR100798499B1/ko not_active IP Right Cessation
- 2000-04-11 ES ES03020049T patent/ES2258688T3/es not_active Expired - Lifetime
- 2000-11-04 US US09/958,328 patent/US6797281B1/en not_active Expired - Lifetime
-
2001
- 2001-09-28 IS IS6095A patent/IS2476B/is unknown
- 2001-10-03 BG BG105971A patent/BG65312B1/bg unknown
- 2001-10-03 BG BG109876A patent/BG109876A/en unknown
- 2001-10-04 IL IL145765A patent/IL145765A/en not_active IP Right Cessation
- 2001-10-12 NO NO20014985A patent/NO327742B1/no not_active IP Right Cessation
- 2001-10-12 HR HR20010740A patent/HRP20010740B1/xx not_active IP Right Cessation
- 2001-11-12 ZA ZA200109291A patent/ZA200109291B/en unknown
-
2002
- 2002-06-12 HK HK02104388.0A patent/HK1045145B/zh not_active IP Right Cessation
-
2003
- 2003-07-23 US US10/624,645 patent/US7629003B2/en not_active Expired - Fee Related
-
2004
- 2004-01-28 US US10/765,091 patent/US20040186175A1/en not_active Abandoned
- 2004-10-29 AU AU2004224958A patent/AU2004224958B2/en not_active Ceased
-
2006
- 2006-05-01 IL IL175366A patent/IL175366A/en not_active IP Right Cessation
- 2006-12-14 HK HK06113747A patent/HK1092732A1/xx not_active IP Right Cessation
-
2007
- 2007-03-27 US US11/727,526 patent/US7585519B2/en not_active Expired - Fee Related
- 2007-08-23 IL IL185486A patent/IL185486A0/en not_active IP Right Cessation
-
2008
- 2008-03-07 IS IS8719A patent/IS2539B/is unknown
- 2008-12-30 NO NO20085413A patent/NO336949B1/no not_active IP Right Cessation
-
2010
- 2010-09-21 JP JP2010210849A patent/JP5420507B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20085413L (no) | Anvendelse av estere av L-karnitin eller alkanoyl L-karnitiner som kationiske lipider for intracellulær avlevering av farmakologisk aktive forbindelser | |
| PT1075461E (pt) | Esteres perfluorinados de l-carnitina de alcanoilo para a preparacao de lipidoscationicos para a libertacao intracelular de compostos farmacologicamente activos |